Adults 65 and older can earn between $50 and $500 per study visit by participating in aging and longevity research. These aren’t hypothetical figures—they come from actual paid clinical trials and research studies recruiting older adults right now. For example, a vaccine study might pay $50–$150 per visit, while a more intensive drug trial could offer $200–$500 per visit, often with transportation reimbursement and meal stipends ($10–$25) added on top.
This compensation reflects the time commitment and health data required from participants. The market for aging research is substantial and growing. As of 2026, there are 133 active clinical trials actively recruiting volunteers for paid aging studies, with the highest concentration in California, Texas, Florida, and Massachusetts. These aren’t fringe opportunities—they’re part of mainstream medical research and funded by institutions ranging from the National Institutes of Health to private research organizations and biotech companies.
Table of Contents
- How Much Can You Actually Earn in Aging and Longevity Studies?
- What Types of Studies Pay $50–$500 and What Do They Involve?
- Where to Find Active Aging and Longevity Studies Right Now
- The ARPA-H Longevity Initiative and Advanced Aging Research
- Health Screening and Medical Requirements
- Time Commitment and Logistics
- The Future of Aging Research and Participant Demand
- Conclusion
How Much Can You Actually Earn in Aging and Longevity Studies?
The $50–$500 range is real, but understanding where you’ll land within it matters. Single-visit studies typically pay $50–$200, while vaccine studies occupy the lower to middle range at $50–$150. Drug trials—which involve more frequent visits and more intensive monitoring—are where you’ll find the higher payments of $200–$500 per visit. A participant attending a quarterly drug trial for a year might see total earnings in the $800–$2,000 range, though that’s spread across multiple visits. Beyond the per-visit compensation, studies almost universally cover transportation costs and provide meal money.
That $10–$25 in meal and travel reimbursement might sound modest, but it addresses a real barrier for older adults who may not drive or who face higher transportation costs. Some studies also offer childcare assistance or parking reimbursement. The key is that compensation is usually structured as part visit payment plus reimbursable expenses—not a lump sum. One limitation to keep in mind: payment schedules vary. Some studies pay after each visit, others monthly, and some wait until study completion. If you’re relying on the money for immediate expenses, you’ll want to ask about payment timing before enrolling.
What Types of Studies Pay $50–$500 and What Do They Involve?
Studies paying in this range fall into three main categories: observational research, preventive health trials, and drug efficacy studies. Observational studies—where researchers track your health data, lifestyle, or biomarkers over time—typically pay on the lower end ($50–$150). These might involve quarterly clinic visits where blood is drawn, cognitive tests are performed, or health questionnaires are completed. They’re less invasive but require longer-term commitment. Drug trials and vaccine studies occupy the middle to high end of the compensation spectrum. These require closer medical supervision, more frequent visits, and potential side effect monitoring.
The higher pay reflects the actual risks and time investment. For instance, a longevity drug trial might require monthly visits for a year, plus baseline and follow-up visits, accumulating to $3,000–$5,000 in total compensation. But this also means you’re undergoing more extensive health screening, blood work, and potentially taking an investigational medication. A critical warning: higher compensation often correlates with greater health risks and time demands. A $500-per-visit drug trial isn’t necessarily better than a $100-per-visit observational study if the drug trial requires you to travel two hours away or undergo invasive procedures. Read the study protocol carefully, not just the payment amount. Some participants also experience side effects or medical complications that aren’t anticipated in the compensation structure.
Where to Find Active Aging and Longevity Studies Right Now
The largest and most reliable source is ClinicalTrials.gov, a government database maintained by the National Library of Medicine. You can search by age, location, and study type. It lists 133 active aging studies currently recruiting as of 2026. Organizations actively recruiting older adults include Flourish research, Velocity Clinical Trials, and CenExel Research—all of which have dedicated programs for adults 65 and older. The Marcus Institute for Aging Research also maintains a “Join a Research Study” page that specifically targets older adults and lists longevity research opportunities.
This is a credible source because it’s attached to an academic institution focused on aging research, so the studies listed tend to be rigorous and well-funded. The NIH itself encourages adults 65+ to participate, recognizing that many clinical trials have historically under-enrolled older adults, which skewed research findings. Geographic concentration is worth noting. If you live in California, Texas, Florida, or Massachusetts, you’ll have significantly more options than in rural or less populated areas. This creates a practical challenge for older adults outside these regions—you may need to travel or may have fewer choices. Some studies offer telehealth components to address this, though in-person visits are usually required at least for initial screening and final assessments.
The ARPA-H Longevity Initiative and Advanced Aging Research
In 2026, the Advanced Research Projects Agency for Health (ARPA-H) committed up to $52 million to the Buck Institute’s PATH (Platform for Aging Research and Therapeutics Health) project, which represents a significant expansion in longevity research funding and recruitment. PATH is specifically recruiting healthy adults 50 and older with wearable monitoring technology and advanced analytics to track aging biomarkers over time. This project pays for participation and also provides participants with personalized health data and insights—a benefit beyond monetary compensation. The practical advantage of ARPA-H and similar well-funded initiatives is that they tend to have longer timelines, better infrastructure, and more robust participant support.
Rather than a one-off $200 payment for a single visit, you might be enrolled in a multi-year study with quarterly payments, ongoing health coaching, and access to research findings. However, the tradeoff is that wearable monitoring studies require consistent engagement—you’re agreeing to wear devices and provide data regularly, not just show up for occasional clinic visits. This represents a shift in how aging research is conducted. Older approaches relied on clinical visits and questionnaires; newer approaches use continuous biometric data. For participants, this means more flexibility (you can participate from home) but also more accountability (you’re expected to consistently wear and use devices).
Health Screening and Medical Requirements
Before enrolling in any paid aging study, you’ll undergo health screening. This typically includes a medical history review, baseline blood work, cognitive assessment, and sometimes imaging (X-rays or ultrasound). The screening phase itself may or may not be compensated, and this varies by study. Some pay for screening; others don’t. This is an important question to ask upfront. The health requirements are real and sometimes exclusionary. Studies focused on “healthy aging” may exclude participants with uncontrolled diabetes, recent heart attacks, or dementia.
Others are specifically designed for people with certain conditions. If you have multiple comorbidities or take many medications, you might find yourself ineligible for certain studies, even if you’re motivated to participate. This is a safety measure—researchers don’t want to expose participants to risk if an existing condition makes the study dangerous for you. One limitation that surprises many older adults: cognitive capacity is often assessed. Some studies include a Montreal Cognitive Assessment or similar test. If you score below a certain threshold, you may be excluded or placed in a different study category. This protects research integrity but can be disappointing if you expected to participate and suddenly don’t qualify.
Time Commitment and Logistics
The time investment varies enormously. A single-visit vaccine study might require two hours total (check-in, administration, observation period). A drug trial or observational study often requires 2–4 hours per visit, plus travel time. Over a year, a quarterly study means 8–16 hours of clinic time. Add 30–60 minutes per visit for travel, and you’re looking at 12–24 hours annually, or about 30 minutes per month on average.
This sounds manageable until you factor in real-world logistics. If you don’t drive, you’re dependent on a ride, public transit, or study-provided transportation. If the clinic is 45 minutes away, a “2-hour visit” becomes a 3.5-hour commitment. Older adults with mobility issues, chronic pain, or family caregiving responsibilities may find the logistics more challenging than younger participants would. Some studies offer mobile clinics or telehealth components, but these are less common than traditional clinic-based research.
The Future of Aging Research and Participant Demand
Demand for older adult research participants is increasing, not decreasing. As the population ages, more research focuses on age-related diseases, preventive interventions, and longevity strategies. The NIH actively encourages adults 65+ to participate, noting that many past trials excluded older adults or focused on younger populations, which limits applicability.
This growing focus means more studies, more recruitment efforts, and potentially more opportunities for compensation. Emerging research areas include digital health monitoring, genetic testing for aging-related conditions, and preventive drug trials. These newer studies often pay competitively because they’re novel and require participants to engage with technology or take investigational treatments. For older adults comfortable with wearables and digital health tools, this opens up new opportunities beyond traditional clinic visits.
Conclusion
Paid aging and longevity studies offer real compensation—$50–$500 per visit—for adults 65 and older, with 133 active trials currently recruiting as of 2026. The money is genuine, but it’s paired with legitimate time commitments, health requirements, and logistics considerations. Whether a study makes sense for you depends on your health status, location, schedule, and comfort with research participation.
Your next step is to start searching. Visit ClinicalTrials.gov, explore Flourish Research or Velocity Clinical Trials, or check the Marcus Institute for Aging Research. Read study protocols carefully, ask about payment timing and health requirements, and be honest about your time availability. Paid research isn’t a replacement for income, but it can offset medical expenses and contribute meaningfully to your monthly budget while advancing science that benefits millions of older adults.
